Eisai
Brian Harraka, CPA, CGMA, serves as the Chief Financial Officer at Eisai US, having previously held roles such as VP, Deputy Chief Financial Officer, and Corporate Controller. Prior experience includes positions at Novartis, where Brian was Executive Director of Accounting and held various directorship roles in Business Unit Finance, Cost Operations, and Revenue Accounting. Earlier in Brian's career, managerial responsibilities in Financial Planning and Reporting were undertaken at Reckitt Benckiser, and assurance services were provided as a Senior Associate at KPMG Peat Marwick. Brian Harraka holds degrees from Montclair State University and Babson College.
This person is not in any offices
Eisai
12 followers
Eisai Co., Ltd. is engaged in the research and development, manufacture, sale and import and export of pharmaceuticals. The Company's business segments include pharmaceutical segment and other segment. The pharmaceutical segment is engaged in the research, develop, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The other segment consists of pharmaceutical raw materials, logistics services and business services businesses.